Future Directions in GLP-1 Agonist Research for Parkinson's Disease

This chapter examines the potential role of GLP-1 receptor agonists in treating Parkinson's disease, addressing the challenges and limitations observed in recent clinical trials. The discussion emphasizes the need for deeper research into drug mechanisms, brain penetration, and appropriate clinical outcomes, alongside the complexities of patient recruitment and efficacy measurement.